Header image

Bridging the valley: From bench to early phase

Tracks
Track 2
Thursday, October 31, 2024
2:20 PM - 3:05 PM

Overview

Sponsored by: CYTIVA


Details

Join our panellists as we discuss the leap across the valley to early phase human clinical trials. Each of the panel are ready to share their journeys over the hurdles of scaling, showcasing their dedication to pushing the boundaries of innovation. Embarking on human early phase trials brings a blend of awe and excitement. At this pivotal moment, the focus sharpens on guaranteeing safety, refining dosages, and closely monitoring for potential side effects. This stage also underscores the necessity for increased drug substance production, spotlighting the essential task of scaling up operations with precision and care. Scaling up involves more than just boosting numbers; it is an opportunity to delve into the heart of the process, fine-tuning every aspect from reaction conditions to the use of equipment and purification methods.


Speaker

Agenda Item Image
A/Prof. Helen Benham
Executive Director - Translation
Translational Research Institute

Panellist

Ms Janelle Bryce
ANZ Marketing Manager
Global Life Sciences Solutions Australia P/L Trading as Cytiva

Chair

Dr. Pat James
Group Leader, Regulated Biomanufacturing
CSIRO

Panellist

Agenda Item Image
Mr Mark W Womack
Chief Executive Officer
BioCina

Panellist

loading